• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • AUSTRALIA EDITION
      Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • AUSTRALIA EDITION
      North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Minerals
    Tech
    Life Science
    Medical Device Market
    Medical Device News
    Medical Device Stocks
    • Medical Device Market
    • Medical Device News
    • Medical Device Stocks
    Badge
    Accurayorporated
    Accuray is committed to expanding the powerful potential of radiation therapy to improve as many lives as possible.
    medical-device-investing

    Accuray to Report Second Quarter Fiscal 2026 Financial Results on February 4, 2026

    Investing News Network
    Jan. 21, 2026 11:05AM PST
    Medical Device Investing
    Accuray to Report Second Quarter Fiscal 2026 Financial Results on February 4, 2026
    Accuray Incorporated will report financial results for the second quarter of fiscal year 2026, ended December 31, 2025, during a conference call hosted by company management at 1:30 p.m. PT4:30 p.m. ET on February 4, 2026. The conference call dial-in numbers are 1-833-316-0563 or 1-412-317-5747 . In addition, a dial-up replay of the conference call will be available approximately one hour after the call's conclusion ...

    Accuray Incorporated (NASDAQ: ARAY) will report financial results for the second quarter of fiscal year 2026, ended December 31, 2025, during a conference call hosted by company management at 1:30 p.m. PT4:30 p.m. ET on February 4, 2026.

    Accuray Incorporated (PRNewsFoto/Accuray Incorporated) (PRNewsFoto/Accuray Incorporated)

    The conference call dial-in numbers are 1-833-316-0563 (USA) or 1-412-317-5747 (international). In addition, a dial-up replay of the conference call will be available approximately one hour after the call's conclusion for one week. The replay number is 1-855-669-9658 (USA) or 1-412-317-0088 (international), conference ID: 8587254.

    A live webcast of the call will also be available from the Investor Relations section of the company's website at investors.accuray.com. A webcast replay can be accessed on the website and will remain available until Accuray announces its results for the third quarter of fiscal 2026.

    About Accuray
    Accuray is committed to expanding the powerful potential of radiation therapy to improve as many lives as possible. We invent unique, market-changing solutions designed to deliver radiation treatments for even the most complex cases—while making commonly treatable cases even easier—to meet the full spectrum of patient needs. We are dedicated to continuous innovation in radiation therapy for oncology, neuro-radiosurgery, and beyond, as we partner with clinicians and administrators, empowering them to help patients get back to their lives, faster. Accuray is headquartered in Madison, Wisconsin, with facilities worldwide. To learn more, visit www.accuray.com or follow us on Facebook, LinkedIn, X, and YouTube.

    Investor Contact
    Aman Patel, CFA
    Investor Relations, ICR Healthcare
    aman.patel@icrhealthcare.com

    Media Contact
    Steve Monroe
    VP, Financial Planning & Analysis, Accuray
    smonroe@accuray.com

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/accuray-to-report-second-quarter-fiscal-2026-financial-results-on-february-4-2026-302666065.html

    SOURCE Accuray Incorporated

    News Provided by PR Newswire via QuoteMedia

    ARAY
    accurayorporatedarayngs-araymedical-device-investing
    The Conversation (0)

    Go Deeper

    AI Powered

    Latest News

    More News

    Outlook Reports

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Energy
      • Oil and Gas
      • Uranium
    • Critical Metals
      • Rare Earths
    • Agriculture
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Battery Metals
      • Cobalt
      • Graphite
      • Lithium
      • Electric Vehicles
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Robotics
      • Crypto
      • Cleantech
    Life Science
      • Biotech
      • Cannabis
      • Pharmaceuticals

    Featured Medical Device Investing Stocks

    Cardiex Limited

    Cardiex Limited (CDX:AU)
    CDX:AU

    Cleo Diagnostics

    Cleo Diagnostics (COV:AU)
    COV:AU
    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES